Androgen Inhibits Abdominal Fat Accumulation and Negatively Regulates the PCK1 Gene in Male Chickens

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Duan, Jinlin ^a   Shao, Fan ^a   Shao, Yonggang ^b   Li, Junying ^a   Ling, Yao ^a   Teng, Kedao ^a   Li, Hongwei ^a   Wu, Changxin ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b XINJIANG AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN;

ABDOMINAL FAT; ANDROGEN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FAT CONTENT; GENE; GENE EXPRESSION PROFILING; GENETIC CODE; HORMONAL REGULATION; LIPID STORAGE; LIPOGENESIS; MALE; ME1 GENE; MICROARRAY ANALYSIS; MOLECULAR MODEL; NONHUMAN; PHOSPHOENOLPYRUVATE CARBOXYKINASE 1 GENE; UPREGULATION;

ABDOMINAL FAT; ANDROGENS; ANIMALS; CHICKENS; ESTRADIOL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIVER; MALATE DEHYDROGENASE; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RNA, MESSENGER; SIGNAL TRANSDUCTION; TESTOSTERONE;

AVES; GALLUS GALLUS;

EID: 84875459500     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059636     Document Type: Article

References (70)

1. Chen KL, Wu CP, Hong YM, (2000) Meat quality and carcass traits of capon in comparison with intact male and female Taiwan country chickens. J. Chin. Soc. Anim. Sci. 29: 77-88.
2. Fennell MJ, Johnson AL, Scanes CG, (1990) Influence of androgens on serum concentration of growth hormone in growing castrated and intact chickens. Gen. Comp. Endocrinol. 77: 763-766.
3. Fennell MJ, Scanes CG, (1992) Inhibition of growth in chickens by testosterone, 5α-dihydrotestosterone and 19-nortestosterone. Poultry Sci. 71: 357-366.
4. Hsieh CY, Chen KL, Chiou PWS, (2001) The lipoprotein composition and structure of capon and incomplete caponized Taiwan country chicken. J. Chin. Soc. Anim. Sci. 30: 229.
5. Chen KL, Chi WT, Chiou PWS, (2005) Caponization and testosterone implantation effects on blood lipid and lipoprotein profile in male chickens. Poultry Sci. 84: 547-552.
6. Lacasa D, Agli B, Moynard D, Giudicelli Y, (1995) Evidence for a regional specific control of rat preadipocyte proliferation and differentiation by the androgenic status. Endocrine 3: 789-793.
7. Lacasa D, Garcia E, Henriot D, Agli B, (1997) Giudicelli (1997) Site-related specificities of the control by androgenic status of adipogenesis and mitogen-activated protein kinase cascade/c-fos signaling pathways in rat preadipocytes. Endocrinology 138: 3181-3186.
8. Garcia E, Lacasa M, Agli B, Giudicelli Y, Lacasa D, (1999) Modulation of rat preadipocyte adipose conversion by androgenic status: involvement of C/EBPs transcription factors. J. Endocrinol. 161: 89-97.
9. Charles C, Jacques G, Jean B, Arthur SL, Rao DC, et al. (2000) Contribution of body fatness and adipose tissue distribution to the age variation in serum steroid hormone concentrations in men: the HERITAGE Family Study. J. Clin. Endocrinol. Metab. 85: 1026-1031.
10. Rajan S, Jorge NA, Wayne ET, Nestor FG, Shalender B, (2003) Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 144: 5081-5088.
11. Pasquali R, (2006) Obesity and androgens: facts and perspectives. Fertil. Steril. 85: 1319-1340.
12. Karine B, Nadeau MI, Perreault M, Veilleux A, Drolet R, et al. (2010) Effects of androgens on adipocyte differentiation and adipose tissue explant metabolism in men and women. Clin. Endocrinol. 72: 176-188.
13. Chapman MT, (1980) Animal lipoproteins: chemistry, structure and comparative aspects. J. Lipid Res. 21: 789-852.
14. Chen KL, Chi WT, Chu C, Chen RS, Chiou PWS, (2007) Effect of caponization and testosterone implantation on hepatic lipids and lipogenic enzymes in male chickens. Poultry Sci. 86: 1754-1759.
15. Schena M, Shalon D, Davis RW, Brown PO, (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270: 467-470.
16. DeRisi JL, Penland L, Brown PO, Bittner ML, Meltzer PS, et al. (1996) Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet. 14: 457-460.
17. DeRisi JL, Iyer VR, Brown PO, (1997) Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278: 680-686.
18. Kononen J, Lukas B, Anne K, Maarit B, Peter S, et al. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4: 844-847.
19. Duggan DJ, Michael B, Chen YD, Paul M, Trent JM, (1999) Expression profiling using cDNA microarrays. Nat. Genet. 21: 10-14.
20. Shoemaker DD, Schadt EE, Armour CD, He YD, Garrett EP, et al. (2001) Experimental annotation of the human genome using microarray technology. Nature 409: 922-927.
21. David JL, Helin D, Michael CB, Maximillian TF, Michael VG, et al. (1996) Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. 14: 1675-1680.
22. Aron CE, Leah RT, Pengchin C, Roderick VJ, deFeo G, et al. (2006) Replacing cRNA targets with cDNA reduces microarray cross-hybridization. Nat. Biotechnol. 24: 1071-1073.
23. Chen KL, Wu CP, Chou RRG, (2000) Effect of caponization age on growth performance and postmortem change in muscles of Taiwan country chicken. J. Agric. Assoc. Chin. 1: 54-63.
24. Rosalyn SY, Solomon AB (1976) Methods in Radioimmunoassay of Peptide Hormones. North-Holland Pub Co, New York, U.S.A.
25. Rafael AI, (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
26. Storey JD, (2002) A direct approach to false discovery rates. J. Roy. Stat. Soc. Ser. B 64: 479-498.
27. Larionov A, Krause A, Miller W, (2005) A standard curve based method for relative real time PCR data processing. BMC Bioinformatics 21 6: 62.
28. Steel RGD, Torrie JH (1960) Principles and Procedures of Statistics. New York: McGraw.
29. Field RA, (1971) Effect of castration on meat quality and quantity. J. Animal Sci. 32: 849-858.
30. Wilson JD, (1988) Androgen abuse by athletes. Endocr. Rev. 9: 181-199.
31. Bhasin S, Woodhouse L, Storer TW, (2001) Proof of the effect of testosterone on skeletal muscle. J. Endocrinol. 170: 27-38.
32. Pasquali R, Casimirri F, Cantobelli S, Melchionda N, Morselli AM, et al. (1991) Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 40: 101-104.
33. Khaw KT, Barrett-Connor E, (1992) Lower endogenous androgens predict central adiposity in men. Ann. Epidemiol. 2: 675-682.
34. Gapstur SM, Gann PH, Kopp P, Colangelo L, Longcope C, et al. (2002) Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study, Cancer Epidemiol. Biomarker Prev. 11: 1041-1047.
35. Bhasin S, Storer TW, Berman N, Yarasheski KE, Clevenger B, et al. (1997) A replacement dose of testosterone increases fat-free mass and muscle size in hypogonadal men. J. Clin. Endocrinol. Metab. 82: 407-413.
36. Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, et al. (1996) Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J. Clin. Endocrinol. Metab. 81: 4358-4365.
37. Brodsky IG, Balagopal P, Nair KS, (1996) Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men-a clinical research center study. J. Clin. Endocrinol. Metab. 81: 3469-3475.
38. Snyder PJ, Peachey H, Berlin JA, Hannoush P, Haddad G, et al. (2000) Effects of testosterone replacement in hypogonadal men. J. Clin. Endocrinol. Metab. 85: 2670-2677.
39. Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, et al. (2000) Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Testosterone Gel Study Group. J. Clin. Endocrinol. Metab. 85: 2839-2853.
40. Chen KL, Hsieh TY, Chiou PWS, (2006) Caponization effects on growth performance and lipid metabolism in Taiwan country chicken cockerels. Asian-Aust. J. Anim. Sci 19: 438-443.
41. Meraz MA, White JM, Sheehan KCF, Bach EA, Rodig SJ, et al. (1996) Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84: 431-442.
42. Murray PJ, (2007) The Jak-STAT signaling pathway: input and output integration. J. Immunol. 178: 2623-2629.
43. Dostert C, Jouanguy E, Irving P, Troxler L, Arnoux LG, et al. (2005) The Jak-STAT signaling pathway is required but not sufficient for the antiviral response of drosophila. Nat. Immunol. 6: 946-953.
44. Chen KL, Tsay SM, Chiou PWS, Chen TW, Weng BC, (2010) Effect of caponization and testosterone implantation on immunity in male chickens. Poultry Sci. 88: 887-894.
45. Tilghman SM, Ballard FJ, Hanson RW (1976) Hormonal regulation of phosphoenolpyruvate carboxykinase (GTP) in mammalian tissues p. 47-91. In R. W. Hanson and M. A. Mehlman (ed.), Gluconeogenesis: Its Regulation in Mammalian Species. Wiley and Sons, New York.
46. Wicks WD, Lewis W, Mickibbin JB, (1972) Induction of phosphoenolpyruvate carboxykinase by N6, O2′-dibutyryl cyclic amp in rat liver. Biochim. Biophys. Acta. 264: 177-185.
47. Tilghman SM, Hanson RW, Resheft L, Hopgoodt MF, Ballardt FJ, (1974) Rapid loss of translatable messenger RNA of phosphoenolpyruvate carboxykinase during glucose repression in liver. Proc. Natl. Acad. Sci. U. S. A. 71: 1304-1308.
48. Gunn JM, Hanson RW, Meyuhas O, Reshef L, Ballarde FJ, (1975) Glucocorticoids and the regulation of phosphoenolpyruvate carboxykinase (Guanosine Triphosphate) in the rat. Biochem. J. 150: 195-203.
49. Muller MJ, Thomsen A, Sibrowski W, Seitz HJ, (1982) 3,5,3′ Vimiodothyronine-induced synthesis of rat liver phosphoenolpyruvate carboxykinase. Endocrinology 111: 1469-1475.
50. Andreone TL, Beale EG, Bar RS, Granner DK, (1982) Insulin decreases phosphoenolpyruvate carboxykinase (GTP) mRNA activity by a receptor-mediated process. J. Biol. Chem. 257: 35-38.
51. Sasaki K, Cripe TP, Koch SR, Andreone TL, Petersen DD, et al. (1984) Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. J. Biol. Chem. 259: 15242-15251.
52. Zhang Y, Chen W, Li R, Li Y, Ge Y, et al. (2011) Insulin-regulated Srebp-1c and Pck1 mRNA expression in primary hepatocytes from zucker fatty but not lean rats is affected by feeding conditions. PLoS One 6: e21342.
53. Valera A, Pujol A, Pelegrin M, Bosch F, (1994) Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. U. S. A. 91: 9151-9154.
54. She P, Shiota M, Shelton KD, Chalkley R, Postic C, et al. (2000) Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism. Mol. Cell. Biol. 20: 6508-6517.
55. Sun Y, Liu S, Ferguson S, Wang L, Klepcyk P, et al. (2002) Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice. J. Biol. Chem. 277: 23301-23307.
56. She P, Burgess SC, Shiota M, Flakoll P, Donahue EP, et al. (2003) Mechanisms by which liver-specific PEPCK knockout mice preserve euglycemia during starvation. Diabetes 52: 1649-1654.
57. Cao H, vander VE, Ban MR, Hanley AJ, Zinman B, et al. (2004) Promoter polymorphism in PCK1 (phosphoenolpyruvate carboxykinase gene) associated with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 89: 898-903.
58. Hakimi P, Johnson MT, Yang J, Lepage DF, Conlon RA, et al. (2005) Phosphoenolpyruvate carboxykinase and the critical role of cataplerosis in the control of hepatic metabolism. Nutr. Metab. (Lond). 2: 33.
59. Gomez-Valades AG, Vidal-Alabro A, Molas M, Boada J, Bermudez J, et al. (2006) Overcoming diabetes-induced hyperglycemia through inhibition of hepatic phosphoenolpyruvate carboxykinase (GTP) with RNAi. Mol. Ther. 13: 401-410.
60. Beale EG, Harvey BJ, Forest C, (2007) PCK1 and PCK2 as candidate diabetes and obesity genes. Cell. Biochem. Biophys. 48: 89-95.
61. Gomez-Valades AG, Mendez-Lucas A, Vidal-Alabro A, Blasco FX, Chillon M, et al. (2008) Pck1 gene silencing in the liver improves glycemia control, insulin sensitivity, and dyslipidemia in db/db mice. Diabetes 57: 2199-2210.
62. Rees SD, Britten AC, Bellary S, Ohare JP, Kumar S, et al. (2009) The promoter polymorphism -232C/G of the PCK1 gene is associated with type 2 diabetes in a UK-resident South Asian population. BMC Med. Genet. 10: 83.
63. Hsieh CW, Millward CA, DeSantis D, Pisano S, Machova J, et al. (2009) Reduced milk triglycerides in mice lacking phosphoenolpyruvate carboxykinase in mammary gland adipocytes and white adipose tissue contribute to the development of insulin resistance in pups. J. Nutr. 139: 2257-2265.
64. Millward CA, DeSantis D, Hsieh CW, Heaney JD, Pisano S, et al. (2010) Phosphoenolpyruvate carboxykinase (Pck1) helps regulate the triglyceride/fatty acid cycle and development of insulin resistance in mice. J. Lipid Res. 51: 1452-1463.
65. Hsieh CW, Huang C, Bederman I, Yang J, Beidelschies M, et al. (2011) Function of phosphoenolpyruvate carboxykinase in mammary gland epithelial cells. J. Lipid Res. 52: 1352-1362.
66. Cook JS, Sharon LW, Garcia-ruiz JP, Hod Y, Hanson RW, (1986) Nucleotide sequence of the mRNA encoding the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) from the chicken. Proc. Natl. Acad. Sci. U. S. A. 83: 7583-7587.
67. Watford M, Hod Y, Chiao YB, Utter MF, Hanson RW, (1981) The unique role of the kidney in gluconeogenesis in the chicken. J. Biol. Chem. 256: 10023-10027.
68. Marin P, Oden B, Bjorntorp P, (1995) Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J. Clin. Endocrinol. Metab. 80: 239-243.
69. Florence G, Pascal F, Isabelle D, (2001) ADD-1/SREBP-1 is a major determinant of tissue differential lipogenic capacity in mammalian and avian species. J. Lipid Res. 42: 106-113.
70. Earl S, Joseph AG, Edgar SG, (1971) Comparative aspects of lipogenesis in mammalian tissues. Metabolism 20: 54-62.